DRRX Valuation
DURECT Corp
$
1.900
- Overview
- Forecast
- Valuation
- Earnings
DRRX Relative Valuation
DRRX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DRRX is overvalued; if below, it's undervalued.
Historical Valuation
DURECT Corp (DRRX) is now in the Overvalued zone, suggesting that its current forward PS ratio of 54.14 is considered Overvalued compared with the five-year average of -4.51. The fair price of DURECT Corp (DRRX) is between 0.11 to 0.85 according to relative valuation methord. Compared to the current price of 1.90 USD , DURECT Corp is Overvalued By 123.36%.
Relative Value
Fair Zone
0.11-0.85
Current Price：1.90
123.36%
Overvalued
-2.81
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
DURECT Corp. (DRRX) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
-2.00
EV/EBIT
DURECT Corp. (DRRX) has a current EV/EBIT of -2.00. The 5-year average EV/EBIT is -3.40. The thresholds are as follows: Strongly Undervalued below -10.14, Undervalued between -10.14 and -6.77, Fairly Valued between -0.04 and -6.77, Overvalued between -0.04 and 3.33, and Strongly Overvalued above 3.33. The current Forward EV/EBIT of -2.00 falls within the Historic Trend Line -Fairly Valued range.
54.14
PS
DURECT Corp. (DRRX) has a current PS of 54.14. The 5-year average PS is 13.41. The thresholds are as follows: Strongly Undervalued below -13.05, Undervalued between -13.05 and 0.18, Fairly Valued between 26.64 and 0.18, Overvalued between 26.64 and 39.87, and Strongly Overvalued above 39.87. The current Forward PS of 54.14 falls within the Strongly Overvalued range.
0.00
P/OCF
DURECT Corp. (DRRX) has a current P/OCF of 0.00. The 5-year average P/OCF is -1.76. The thresholds are as follows: Strongly Undervalued below -9.58, Undervalued between -9.58 and -5.67, Fairly Valued between 2.16 and -5.67, Overvalued between 2.16 and 6.07, and Strongly Overvalued above 6.07. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
DURECT Corp. (DRRX) has a current P/FCF of 0.00. The 5-year average P/FCF is -2.97. The thresholds are as follows: Strongly Undervalued below -13.83, Undervalued between -13.83 and -8.40, Fairly Valued between 2.45 and -8.40, Overvalued between 2.45 and 7.88, and Strongly Overvalued above 7.88. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
DURECT Corp (DRRX) has a current Price-to-Book (P/B) ratio of 17.02. Compared to its 3-year average P/B ratio of 7.88 , the current P/B ratio is approximately 116.11% higher. Relative to its 5-year average P/B ratio of 7.07, the current P/B ratio is about 140.69% higher. DURECT Corp (DRRX) has a Forward Free Cash Flow (FCF) yield of approximately -23.55%. Compared to its 3-year average FCF yield of -66.78%, the current FCF yield is approximately -64.74% lower. Relative to its 5-year average FCF yield of -45.88% , the current FCF yield is about -48.68% lower.
17.02
P/B
Median3y
7.88
Median5y
7.07
-23.55
FCF Yield
Median3y
-66.78
Median5y
-45.88
Competitors Valuation Multiple
The average P/S ratio for DRRX's competitors is 12.72, providing a benchmark for relative valuation. DURECT Corp Corp (DRRX) exhibits a P/S ratio of 54.14, which is 325.65% above the industry average. Given its robust revenue growth of -99.12%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of DRRX increased by 28.38% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -170.43 to -11.92K.
The secondary factor is the Revenue Growth, contributed -99.12%to the performance.
Overall, the performance of DRRX in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
PZG
Paramount Gold Nevada Corp
0.765
USD
+7.60%
CVV
CVD Equipment Corp
2.960
USD
+0.54%
IGC
IGC Pharma Inc
0.380
USD
+2.70%
NAII
Natural Alternatives International Inc
3.860
USD
+0.52%
CPSH
CPS Technologies Corp
3.260
USD
+2.19%
NXGL
Nexgel Inc
2.306
USD
-5.10%
NISN
Nisun International Enterprise Development Group Co Ltd
3.800
USD
+1.06%
MRKR
Marker Therapeutics Inc
1.210
USD
-3.97%
XCUR
Exicure Inc
6.550
USD
-1.50%
FAQ
Is DURECT Corp (DRRX) currently overvalued or undervalued?
DURECT Corp (DRRX) is now in the Overvalued zone, suggesting that its current forward PS ratio of 54.14 is considered Overvalued compared with the five-year average of -4.51. The fair price of DURECT Corp (DRRX) is between 0.11 to 0.85 according to relative valuation methord. Compared to the current price of 1.90 USD , DURECT Corp is Overvalued By 123.36% .
What is DURECT Corp (DRRX) fair value?
How does DRRX's valuation metrics compare to the industry average?
What is the current P/B ratio for DURECT Corp (DRRX) as of Aug 19 2025?
What is the current FCF Yield for DURECT Corp (DRRX) as of Aug 19 2025?
What is the current Forward P/E ratio for DURECT Corp (DRRX) as of Aug 19 2025?